THE Therapeutic Goods Administration (TGA) has added an Australian Public Assessment Report (AusPAR) for Teva Pharma's Seasonique (levonorgestrel/ethinyloestradiol) combination oral contraceptive.
The tablets are film-coated immediate release in a 91-day regimen of 84 combination tablets and seven mono tablets of ethinyloestradiol - tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Dec 16
